lrust's library 358 articles Export

Ordered by to_read.

	What Is the Role for the Circumferential Margin in the Modern Treatment of Rectal Cancer? [My Copy] J Clin Oncol, Vol. 26, No. 2. (10 January 2008), pp. 303-312. by Iris D. Nagtegaal, Phil Quirke posted to rectal by lrust on 2008-01-12 15:00:25 as
	Randomized Phase II Trial of First-Line Treatment With Sorafenib Versus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma [My Copy] J Clin Oncol, Vol. 27, No. 8. (10 March 2009), pp. 1280-1289. by Bernard Escudier, Cezary Szczylik, Thomas E. Hutson, et al.Tomasz Demkow, Michael Staehler, Frederic Rolland, Sylvie Negrier, Nicole Laferriere, Urban J. Scheuring, David Cella, Sonalee Shah, Ronald M. Bukowski posted to rcc by lrust on 2009-07-20 04:00:39 as
	Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation With MGMT Promoter Methylation Status [My Copy] J Clin Oncol, Vol. 27, No. 8. (10 March 2009), pp. 1275-1279. by Alba A. Brandes, Alicia Tosoni, Enrico Franceschi, et al.Guido Sotti, Giampiero Frezza, Pietro Amista, Luca Morandi, Federica Spagnolli, Mario Ermani posted to gbm by lrust on 2009-07-20 03:58:42 as
	Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non-Small-Cell Lung Cancer: AVAiL [My Copy] J Clin Oncol, Vol. 27, No. 8. (10 March 2009), pp. 1227-1234. by Martin Reck, Joachim von Pawel, Petr Zatloukal, et al.Rodryg Ramlau, Vera Gorbounova, Vera Hirsh, Natasha Leighl, Jorg Mezger, Venice Archer, Nicola Moore, Christian Manegold posted to nsclc by lrust on 2009-07-20 03:56:33 as
	Outcome of Deferred Initial Therapy in Mantle-Cell Lymphoma [My Copy] J Clin Oncol, Vol. 27, No. 8. (10 March 2009), pp. 1209-1213. by Peter Martin, Amy Chadburn, Paul Christos, et al.Karen Weil, Richard R. Furman, Jia Ruan, Rebecca Elstrom, Ruben Niesvizky, Scott Ely, Maurizio Diliberto, Ari Melnick, Daniel M. Knowles, Selina Chen-Kiang, Morton Coleman, John P. Leonard posted to mcl by lrust on 2009-07-20 03:55:49 as
	Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735 [My Copy] J Clin Oncol, Vol. 27, No. 8. (10 March 2009), pp. 1177-1183. by Stephen Jones, Frankie A. Holmes, Joyce O'Shaughnessy, et al.Joanne L. Blum, Svetislava J. Vukelja, Kristi J. McIntyre, John E. Pippen, James H. Bordelon, Robert L. Kirby, John Sandbach, William J. Hyman, Donald A. Richards, Robert G. Mennel, Kristi A. Boehm, Wally G. Meyer, Lina Asmar, Daniel Mackey, Stefan Riedel, Hyman Muss, Michael A. Savin posted to breast by lrust on 2009-07-20 03:55:10 as along with 1 person merpublic
	Anthracyclines and Early Breast Cancer: The End of an Era? [My Copy] J Clin Oncol, Vol. 27, No. 8. (10 March 2009), pp. 1155-1157. by Luca Gianni, Pinuccia Valagussa posted to breast by lrust on 2009-07-20 03:53:59 as
	Introducing molecular subtyping of breast cancer into the clinic? [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 27, No. 8. (10 March 2009), pp. 1153-1154. by Therese Sørlie posted to breast by lrust on 2009-07-20 03:53:06 as along with 1 person jfr
	Use of 5-alpha-Reductase Inhibitors for Prostate Cancer Chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline [My Copy] J Clin Oncol, Vol. 27, No. 9. (20 March 2009), pp. 1502-1516. by Barnett S. Kramer, Karen L. Hagerty, Stewart Justman, et al.Mark R. Somerfield, Peter C. Albertsen, William J. Blot, H. Ballentine Carter, Joseph P. Costantino, Jonathan I. Epstein, Paul A. Godley, Russell P. Harris, Timothy J. Wilt, Janet Wittes, Robin Zon, Paul Schellhammer posted to prostate by lrust on 2009-07-20 03:49:55 as
	Bendamustine: Rebirth of an Old Drug [My Copy] J Clin Oncol, Vol. 27, No. 9. (20 March 2009), pp. 1492-1501. by Bruce D. Cheson, Mathias J. Rummel posted to chemotherapy general by lrust on 2009-07-20 03:48:38 as along with 1 person subhoghosh
	First-Line Gefitinib for Patients With Advanced Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for Chemotherapy [My Copy] J Clin Oncol, Vol. 27, No. 9. (20 March 2009), pp. 1394-1400. by Akira Inoue, Kunihiko Kobayashi, Kazuhiro Usui, et al.Makoto Maemondo, Shoji Okinaga, Iwao Mikami, Masahiro Ando, Koichi Yamazaki, Yasuo Saijo, Akihiko Gemma, Hitoshi Miyazawa, Tomoaki Tanaka, Kenji Ikebuchi, Toshihiro Nukiwa, Satoshi Morita, Koichi Hagiwara posted to nsclc by lrust on 2009-07-20 03:46:40 as
	Breast Cancer With Synchronous Metastases: Survival Impact of Exclusive Locoregional Radiotherapy [My Copy] J Clin Oncol, Vol. 27, No. 9. (20 March 2009), pp. 1375-1381. by Romuald Le Scodan, Denise Stevens, Etienne Brain, et al.Jean L. Floiras, Christine Cohen-Solal, Brigitte De La Lande, Michelle Tubiana-Hulin, Sameh Yacoub, Maya Gutierrez, David Ali, Miriam Gardner, Patricia Moisson, Sylviane Villette, Florence Lerebours, Jean N. Munck, Alain Labib posted to breast by lrust on 2009-07-20 03:44:24 as
	Contralateral Prophylactic Mastectomy: Caveat Emptor [My Copy] J Clin Oncol, Vol. 27, No. 9. (20 March 2009), pp. 1347-1349. by Abram Recht posted to breast by lrust on 2009-07-20 03:43:32 as
	The "Lazarus Response" in Treatment-Naive, Poor Performance Status Patients With Non-Small-Cell Lung Cancer and Epidermal Growth Factor Receptor Mutation [My Copy] J Clin Oncol, Vol. 27, No. 9. (20 March 2009), pp. 1350-1354. by Corey J. Langer posted to nsclc by lrust on 2009-07-20 03:36:22 as
	Reply to C.A. Dasanu et al [My Copy] J Clin Oncol, Vol. 27, No. 13. (1 May 2009), pp. 2294-2296. by Asher A. Chanan-Khan, Pieter Sonneveld, Jean-Luc Harousseau, Paul G. Richardson posted to myeloma by lrust on 2009-07-20 03:34:14 as
	Chemoradiotherapy in the Management of Locally Advanced Pancreatic Carcinoma: A Qualitative Systematic Review [My Copy] J Clin Oncol, Vol. 27, No. 13. (1 May 2009), pp. 2269-2277. by Florence Huguet, Nicolas Girard, Clotilde S. Guerche, Christophe Hennequin, Francoise Mornex, David Azria posted to pancreatic by lrust on 2009-07-20 03:31:27 as
	Autologous Stem-Cell Transplantation in Patients With HIV-Related Lymphoma [My Copy] J Clin Oncol, Vol. 27, No. 13. (1 May 2009), pp. 2192-2198. by Pascual Balsalobre, Jose L. Diez-Martin, Alessandro Re, et al.Mariagrazia Michieli, Jose M. Ribera, Carmen Canals, Anne Rosselet, Eulogio Conde, Rosario Varela, Kate Cwynarski, Ian Gabriel, Philippe Genet, Gaelle Guillerm, Bernardino Allione, Augustin Ferrant, Pierre Biron, Ildefonso Espigado, David Serrano, Anna Sureda posted to immunodeficiency lymphoma transplant by lrust on 2009-07-20 03:30:15 as
	Variations on the Fludarabine, Cyclophosphamide, and Rituximab Combination in Chronic Lymphocytic Leukemia Therapy: What Have We Learned? [My Copy] J Clin Oncol, Vol. 27, No. 4. (1 February 2009), pp. 479-480. by Tahamtan Ahmadi, Stephen J. Schuster posted to cll by lrust on 2009-07-20 03:26:11 as
	Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab [My Copy] J Clin Oncol, Vol. 27, No. 4. (1 February 2009), pp. 605-611. by Winnie Yeo, Tung C. Chan, Nancy W. Y. Leung, et al.Wai Y. Lam, Frankie K. F. Mo, Miu T. Chu, Henry L. Y. Chan, Edwin P. Hui, Kenny I. K. Lei, Tony S. K. Mok, Paul K. S. Chan posted to nhl by lrust on 2009-07-20 03:22:12 as
	Phase III Study of Immediate Compared With Delayed Docetaxel After Front-Line Therapy With Gemcitabine Plus Carboplatin in Advanced Non-Small-Cell Lung Cancer [My Copy] J Clin Oncol, Vol. 27, No. 4. (1 February 2009), pp. 591-598. by Panos M. Fidias, Shaker R. Dakhil, Alan P. Lyss, et al.David M. Loesch, David M. Waterhouse, Jane L. Bromund, Ruqin Chen, Maria Hristova-Kazmierski, Joseph Treat, Coleman K. Obasaju, Martin Marciniak, John Gill, Joan H. Schiller posted to nsclc by lrust on 2009-07-20 03:20:45 as
	Treatment Outcome and Survival Associated With Metastatic Renal Cell Carcinoma of Non-Clear-Cell Histology [My Copy] J Clin Oncol, Vol. 20, No. 9. (1 May 2002), pp. 2376-2381. by Robert J. Motzer, Jennifer Bacik, Tania Mariani, Paul Russo, Madhu Mazumdar, Victor Reuter posted to rcc by lrust on 2009-07-20 03:19:23 as
	Mantle Cell Lymphoma: At Last, Some Hope for Successful Innovative Treatment Strategies [My Copy] J Clin Oncol, Vol. 23, No. 4. (1 February 2005), pp. 657-658. by Richard I. Fisher posted to mcl by lrust on 2009-07-20 03:15:11 as
	Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience [My Copy] J Clin Oncol, Vol. 23, No. 12. (20 April 2005), pp. 2763-2771. by Jean-Jacques Patard, Emmanuelle Leray, Nathalie Rioux-Leclercq, et al.Luca Cindolo, Vincenzo Ficarra, Amnon Zisman, Alexandre De La Taille, Jacques Tostain, Walter Artibani, Claude C. Abbou, Bernard Lobel, Francois Guille, Dominique K. Chopin, Peter F. A. Mulders, Christopher G. Wood, David A. Swanson, Robert A. Figlin, Arie S. Belldegrun, Allan J. Pantuck posted to rcc by lrust on 2009-07-20 03:13:57 as
	Effect of Margin Status on Local Recurrence After Breast Conservation and Radiation Therapy for Ductal Carcinoma In Situ [My Copy] J Clin Oncol, Vol. 27, No. 10. (1 April 2009), pp. 1615-1620. by Clive Dunne, John P. Burke, Monica Morrow, Malcolm R. Kell posted to breast dcis by lrust on 2009-07-20 03:11:34 as
	Cancer Treatment-Induced Bone Loss in Breast and Prostate Cancer [My Copy] J Clin Oncol, Vol. 26, No. 33. (20 November 2008), pp. 5465-5476. by Fred Saad, Jonathan D. Adachi, Jacques P. Brown, et al.Leah A. Canning, Karen A. Gelmon, Robert G. Josse, Kathleen I. Pritchard posted to breast prostate by lrust on 2009-07-20 03:10:12 as along with 1 person and 2 groups songpku Roswell Cancer Crosstalk Breast Cancer Reading Club
	Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 0402 [My Copy] J Clin Oncol, Vol. 26, No. 33. (20 November 2008), pp. 5401-5406. by Akira Inoue, Shunichi Sugawara, Koichi Yamazaki, et al.Makoto Maemondo, Toshiro Suzuki, Kazunori Gomi, Shingo Takanashi, Chieko Inoue, Minoru Inage, Hiroshi Yokouchi, Hiroshi Watanabe, Toumei Tsukamoto, Yasuo Saijo, Osamu Ishimoto, Fumihiro Hommura, Toshihiro Nukiwa posted to sclc by lrust on 2009-07-20 03:09:09 as
	Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer: Results From a Large Observational Cohort Study (BRiTE) [My Copy] J Clin Oncol, Vol. 26, No. 33. (20 November 2008), pp. 5326-5334. by Axel Grothey, Mary M. Sugrue, David M. Purdie, et al.Wei Dong, Daniel Sargent, Eric Hedrick, Mark Kozloff posted to colon by lrust on 2009-07-20 03:08:14 as
	Prognosis, Imatinib Dose, and Benefit of Sunitinib in GIST: Knowing the Genotype [My Copy] J Clin Oncol, Vol. 26, No. 33. (20 November 2008), pp. 5322-5325. by Ian R. Judson posted to gist by lrust on 2009-07-20 03:06:56 as
	Phase III, Double-Blind, Randomized Study Comparing Lapatinib Plus Paclitaxel With Placebo Plus Paclitaxel As First-Line Treatment for Metastatic Breast Cancer [My Copy] J Clin Oncol, Vol. 26, No. 34. (1 December 2008), pp. 5544-5552. by Angelo Di Leo, Henry L. Gomez, Zeba Aziz, et al.Zanete Zvirbule, Jose Bines, Michael C. Arbushites, Stephanie F. Guerrera, Maria Koehler, Cristina Oliva, Steven H. Stein, Lisa S. Williams, Judy Dering, Richard S. Finn, Michael F. Press posted to breast by lrust on 2009-07-20 03:04:00 as
	Fluorouracil Should Continue to Be Incorporated in the Treatment of Localized Esophageal Cancer [My Copy] J Clin Oncol, Vol. 27, No. 3. (20 January 2009), pp. 467-468. by Antoine Adenis, Thierry Conroy posted to esophageal by lrust on 2009-07-20 03:02:23 as
	BRCA Germline Mutations in Jewish Patients With Pancreatic Adenocarcinoma [My Copy] J Clin Oncol, Vol. 27, No. 3. (20 January 2009), pp. 433-438. by Cristina R. Ferrone, Douglas A. Levine, Laura H. Tang, et al.Peter J. Allen, William Jarnagin, Murray F. Brennan, Kenneth Offit, Mark E. Robson posted to pancreatic by lrust on 2009-07-20 03:01:25 as
	Association Between Estrogen Receptor-beta Expression and Epidermal Growth Factor Receptor Mutation in the Postoperative Prognosis of Adenocarcinoma of the Lung [My Copy] J Clin Oncol, Vol. 27, No. 3. (20 January 2009), pp. 411-417. by Naohiro Nose, Kenji Sugio, Tsunehiro Oyama, et al.Tadahiro Nozoe, Hidetaka Uramoto, Teruo Iwata, Takamitsu Onitsuka, Kosei Yasumoto posted to nsclc by lrust on 2009-07-20 03:00:07 as
	Dietary Changes After Breast Cancer in Women Without Hot Flashes: A Simple and Inexpensive Way to Target Tumor and Host? [My Copy] J Clin Oncol, Vol. 27, No. 3. (20 January 2009), pp. 323-325. by Matteo Puntoni, Bernardo Bonanni, Andrea Decensi posted to breast by lrust on 2009-07-20 02:58:45 as
	Natural History of CNS Relapse in Patients With Aggressive Non-Hodgkin's Lymphoma: A 20-Year Follow-Up Analysis of SWOG 8516--The Southwest Oncology Group [My Copy] J Clin Oncol, Vol. 27, No. 1. (1 January 2009), pp. 114-119. by Steven H. Bernstein, Joseph M. Unger, Michael Leblanc, Jonathan Friedberg, Thomas P. Miller, Richard I. Fisher posted to lymphoma neuro nhl by lrust on 2009-07-20 02:56:28 as along with 1 person eisei
	Prophylactic Cranial Irradiation in Extensive Disease Small-Cell Lung Cancer: Short-Term Health-Related Quality of Life and Patient Reported Symptoms--Results of an International Phase III Randomized Controlled Trial by the EORTC Radiation Oncology and Lung Cancer Groups [My Copy] J Clin Oncol, Vol. 27, No. 1. (1 January 2009), pp. 78-84. by Berend J. Slotman, Murielle E. Mauer, Andrew Bottomley, et al.Corinne Faivre-Finn, Gijs W. P. M. Kramer, Elaine M. Rankin, Michael Snee, Matthew Hatton, Pieter E. Postmus, Laurence Collette, Suresh Senan posted to sclc by lrust on 2009-07-20 02:54:58 as
	Intervals Longer Than 20 Weeks From Breast-Conserving Surgery to Radiation Therapy Are Associated With Inferior Outcome for Women With Early-Stage Breast Cancer Who Are Not Receiving Chemotherapy [My Copy] J Clin Oncol, Vol. 27, No. 1. (1 January 2009), pp. 16-23. by Ivo A. Olivotto, Mary L. Lesperance, Pauline T. Truong, et al.Alan Nichol, Tanya Berrang, Scott Tyldesley, Francois Germain, Caroline Speers, Elaine Wai, Caroline Holloway, Winkle Kwan, Hagen Kennecke posted to breast by lrust on 2009-07-20 02:54:07 as
	Clinical Model to Predict Survival in Chemonaive Patients With Advanced Non-Small-Cell Lung Cancer Treated With Third-Generation Chemotherapy Regimens Based on Eastern Cooperative Oncology Group Data [My Copy] J Clin Oncol, Vol. 23, No. 1. (1 January 2005), pp. 175-183. by Tien Hoang, Ronghui Xu, Joan H. Schiller, Philip Bonomi, David H. Johnson posted to nsclc by lrust on 2009-05-22 20:45:10 as
	Treatment of Advanced Non-Small-Cell Lung Cancer in the Elderly: Results of an International Expert Panel [My Copy] J Clin Oncol, Vol. 23, No. 13. (1 May 2005), pp. 3125-3137. by Cesare Gridelli, Matti Aapro, Andrea Ardizzoni, et al.Lodovico Balducci, Filippo De Marinis, Karen Kelly, Thierry Le Chevalier, Christian Manegold, Francesco Perrone, Rafael Rosell, Frances Shepherd, Luigi De Petris, Massimo Di Maio, Corey Langer posted to nsclc by lrust on 2009-05-22 20:43:52 as
	Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non-Small-Cell Lung Cancer: A Multicenter Phase II Trial [My Copy] J Clin Oncol, Vol. 21, No. 9. (1 May 2003), pp. 1752-1759. by Daniel C. Betticher, Hsu, Martin Totsch, et al.Eva Hansen, Christine Joss, Christian von Briel, Ralph A. Schmid, Miklos Pless, James Habicht, Arnaud D. Roth, Anastase Spiliopoulos, Rolf Stahel, Walter Weder, Roger Stupp, Fritz Egli, Markus Furrer, Hanspeter Honegger, Martin Wernli, Thomas Cerny, Hans-Beat Ris posted to nsclc by lrust on 2009-05-22 20:40:06 as
	Consolidation Docetaxel After Concurrent Chemoradiotherapy in Stage IIIB Non-Small-Cell Lung Cancer: Phase II Southwest Oncology Group Study S9504 [My Copy] J Clin Oncol, Vol. 21, No. 10. (15 May 2003), pp. 2004-2010. by David R. Gandara, Kari Chansky, Kathy S. Albain, et al.Bryan R. Leigh, Laurie E. Gaspar, Primo N. Lara, Howard Burris, Paul Gumerlock, Philip J. Kuebler, James D. Bearden, John Crowley, Robert Livingston posted to nsclc by lrust on 2009-05-22 20:38:58 as
	Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non-Small-Cell Lung Cancer: The TAX 326 Study Group [My Copy] J Clin Oncol, Vol. 21, No. 16. (15 August 2003), pp. 3016-3024. by Frank Fossella, Jose R. Pereira, Joachim von Pawel, et al.Anna Pluzanska, Vera Gorbounova, Eckhard Kaukel, Karin V. Mattson, Rodryg Ramlau, Aleksandra Szczesna, Panagiotis Fidias, Michael Millward, Chandra P. Belani posted to nsclc by lrust on 2009-05-22 20:35:31 as
	Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805 [My Copy] J Clin Oncol, Vol. 13, No. 8. (1 August 1995), pp. 1880-1892. by K. S. Albain, V. W. Rusch, J. J. Crowley, et al.T. W. Rice, At Turrisi, J. K. Weick, V. A. Lonchyna, C. A. Presant, R. J. Mckenna, D. R. Gandara posted to nsclc by lrust on 2009-05-22 20:33:49 as
	Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non-Small-Cell Lung Cancer [My Copy] J Clin Oncol, Vol. 26, No. 21. (20 July 2008), pp. 3543-3551. by Giorgio V. Scagliotti, Purvish Parikh, Joachim von Pawel, et al.Bonne Biesma, Johan Vansteenkiste, Christian Manegold, Piotr Serwatowski, Ulrich Gatzemeier, Raghunadharao Digumarti, Mauro Zukin, Jin S. Lee, Anders Mellemgaard, Keunchil Park, Shehkar Patil, Janusz Rolski, Tuncay Goksel, Filippo de Marinis, Lorinda Simms, Katherine P. Sugarman, David Gandara posted to nsclc by lrust on 2009-05-22 20:28:21 as
	Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma [My Copy] Blood, Vol. 113, No. 15. (9 April 2009), pp. 3435-3442. by Heinz Ludwig, Roman Hajek, Elena Tothova, et al.Johannes Drach, Zdenek Adam, Boris Labar, Miklos Egyed, Ivan Spicka, Heinz Gisslinger, Richard Greil, Ingrid Kuhn, Niklas Zojer, Axel Hinke posted to myeloma by lrust on 2009-05-17 15:06:35 as
	Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention [My Copy] Blood, Vol. 113, No. 15. (9 April 2009), pp. 3406-3417. by Eleftherios C. Vamvakas, Morris A. Blajchman posted to transfusion by lrust on 2009-05-17 15:06:03 as
	Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival [My Copy] Blood, Vol. 113, No. 16. (16 April 2009), pp. 3773-3780. by Nathalie A. Johnson, Merrill Boyle, Ali Bashashati, et al.Stephen Leach, Angela Brooks-Wilson, Laurie H. Sehn, Mukesh Chhanabhai, Ryan R. Brinkman, Joseph M. Connors, Andrew P. Weng, Randy D. Gascoyne posted to lymphoma nhl by lrust on 2009-05-17 15:04:31 as
	How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation [My Copy] Blood, Vol. 113, No. 14. (2 April 2009), pp. 3147-3153. by Raymond Liang posted to general immunodeficiency lymphoma nhl by lrust on 2009-05-17 14:58:13 as
	New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment [My Copy] Blood, Vol. 113, No. 13. (26 March 2009), pp. 2895-2901. by Francisco Cervantes, Brigitte Dupriez, Arturo Pereira, et al.Francesco Passamonti, John T. Reilly, Enrica Morra, Alessandro M. Vannucchi, Ruben A. Mesa, Jean-Loup Demory, Giovanni Barosi, Elisa Rumi, Ayalew Tefferi posted to myelofibrosis by lrust on 2009-05-17 14:54:04 as along with 1 person arpadbatai
	CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL) [My Copy] Blood, Vol. 113, No. 17. (23 April 2009), pp. 3896-3902. by Volkmar Boehme, Norbert Schmitz, Samira Zeynalova, Markus Loeffler, Michael Pfreundschuh posted to neuro nhl by lrust on 2009-05-17 14:51:23 as
	The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course [My Copy] Blood, Vol. 113, No. 18. (30 April 2009), pp. 4171-4178. by Constantine S. Tam, Lynne V. Abruzzo, Katherine I. Lin, et al.Jorge Cortes, Alice Lynn, Michael J. Keating, Deborah A. Thomas, Sherry Pierce, Hagop Kantarjian, Srdan Verstovsek posted to myelofibrosis by lrust on 2009-05-17 14:48:31 as

Note: You may cite this page as: http://www.citeulike.org/user/lrust/order/to_read

Result page: 1 2 3 4 5 6 7 8 Next

breast	37
myeloma	28
nsclc	27
nhl	20
colon	18
neuro	16
cll	15
vte	14
lymphoma	13
mpd	13
cml	10
general	10
melanoma	9
gbm	8
rcc	8
testicular	8
hematology	7
mds	7
pancreatic	7
prostate	7
gastric	6
follicular	5
itp	5
transplant	5
rectal	4
sclc	4
thrombophilia	4
all	3
aml	3
antiphospholipid	3
apl	3
brca	3
cutaneous	3
gist	3
headneck	3
hodgkins	3
immunodeficiency	3
iron	3
mcl	3
transfusion	3
vwd	3
warfarin	3
aids	2
carcinoid	2
chemotherapy	2
dcis	2
dlbcl	2
esophageal	2
hemophilia	2
hit	2
myelofibrosis	2
pnh	2
stroke	2
b12	1
castleman	1
epoietin	1
g6pd	1
hcc	1
hereditary	1
indolent	1
neutropenia	1
ovarian	1
platelets	1
rbc	1
unknownprimary	1

lrust's library 358 articles Export

lrust's tags